Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
94 hedge funds and large institutions have $482M invested in Applied Therapeutics in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 24 closing their positions.
1,040% more call options, than puts
Call options by funds: $4.97M | Put options by funds: $436K
41% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 22
25% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 24
6% more funds holding
Funds holding: 89 → 94 (+5)
1.64% more ownership
Funds ownership: 88.74% → 90.38% (+1.6%)
25% less capital invested
Capital invested by funds: $639M → $482M (-$157M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$26.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.15M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.07M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$6.77M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.17M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.39M |
| 4 |
Millennium Management
New York
|
-$3.86M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.55M |
APLT Hedge Fund Activity: Q2 2024 in Review
94 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2024, worth a combined $482M — down 25% from $639M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new APLT positions and 24 closed out — a net gain of 6 holders — while 31 added to existing stakes and 22 trimmed.
The largest buyer was BlackRock, adding an estimated $26.4M. The largest seller was Laurion Capital Management, cutting an estimated $6.77M.
- 94 institutional investors held Applied Therapeutics (APLT) as of Q2 2024, up from 89 in Q1 2024.
- Funds reported $482M of Applied Therapeutics stock for Q2 2024, down 25% quarter-over-quarter.
- 30 funds opened new Applied Therapeutics positions in Q2 2024 and 24 closed out, a net change of +6 holders.
- The largest Applied Therapeutics buyer in Q2 2024 was BlackRock, an estimated $26.4M added.
- The largest Applied Therapeutics seller in Q2 2024 was Laurion Capital Management, an estimated $6.77M sold.
Based on aggregated 13F filings for Q2 2024.